Anomalous aortic origin of right coronary artery from left coronary cusp: a management conundrum: a case report

A 58-year-old Caucasian female presented to the emergency department with chest pain episodes that were brief, sharp, anterior, non-radiating, and intermittent, with no other associated symptoms. Vital signs were unremarkable, except for elevated blood pressure at 148/85 mm Hg. Basic labs, including cardiac biomarkers, were within normal limits. Chest X-ray showed no acute process, and an electrocardiogram (ECG) showed no findings of ischemia or arrhythmia. Her medical history was significant for type 2 diabetes mellitus, obesity, hypertension, and hyperlipidemia. Home medications included amlodipine, aspirin, atorvastatin, and lisinopril. She had a 40-pack-year smoking history and quit the year before. She denied alcohol or recreational drug use and had no family history of premature CAD or sudden cardiac death. She was diagnosed with reflux and discharged home. She presented again 5 months later with a 15-minute episode of dyspnea and dizziness. Her physical exam was entirely benign, and her workup was negative for the acute coronary syndrome (ACS).

One year later, she was back with persistent palpitations for 24 hours. She felt fatigued and endorsed vague chest discomfort, but no shortness of breath or lightheadedness. She was diagnosed with new-onset atrial fibrillation with a rapid ventricular response. Computerized tomography of the chest revealed no pulmonary embolism. She received intravenous diltiazem with improvement in her heart rate and was discharged home on apixaban and oral diltiazem, with instructions to follow up with cardiology outpatient. Before her cardiology appointment, she presented to the emergency department again with a fluttering sensation in her chest associated with lightheadedness but no pain. Once again, the ACS workup did not reveal any signs of ischemia, and she was discharged home. Two days later, she was seen in the cardiology clinic and scheduled for a 30-day event monitor to assess atrial fibrillation burden, an echocardiogram to rule out structural abnormalities, and an exercise nuclear stress test for ischemia.

Initial ECG showed sinus rhythm, normal axis, and intervals, and no ischemic changes or arrhythmias. A transthoracic echocardiogram revealed normal left ventricle function and no wall motion abnormalities. The left ventricular ejection fraction was 68%. Myocardial perfusion imaging with stress-gated single photon emission computerized tomography (SPECT) and rest SPECT imaging was normal, without evidence of ischemia or infarction. Frequent premature ventricular contractions (PVCs), intermittent ventricular bigeminy, and short bursts of non-sustained ventricular tachycardia were noted at peak exercise and early recovery. A 30-day event monitor revealed sinus rhythm predominantly with an average heart rate of 62 beats per minute, although a few brief episodes of atrial fibrillation were noted. In addition, a 17-beat run of ventricular tachycardia (VT) at a rate of 173 beats per minute was detected on day 20 (Fig. 1). After these findings, her diltiazem was stopped in favor of metoprolol succinate.

Subsequent cardiac catheterization performed to assess for ischemic etiology of the exercise-induced non-sustained ventricular tachycardia showed no evidence of obstructive coronary disease. Interestingly, the dominant right coronary artery was noted to arise from the left coronary cusp with a shared ostium to the left system (Additional file 1: Video S1, Additional file 2: Video S2, Additional file 3: Video S3). In addition, a cardiac coronary computerized tomography scan confirmed the right dominant circulation with RCA arising from the left coronary cusp (Fig. 2) with an interarterial course (Fig. 3). Therefore, the patient was referred for a cardiothoracic surgery consultation. She continued to experience palpitations, lightheadedness, and occasional substernal pressure with exertion. However, in the absence of any signs of true myocardial ischemia (e.g., typical angina, ischemic findings on provocative testing, aborted sudden cardiac death or arrest, or non-vagally-mediated arrhythmia), and due to the lack of consensus regarding surgical treatment of AAORCA, a shared decision was made for conservative management per patient preference after multidisciplinary team discussion. The conservative management included restriction of vigorous exercise, up-titration of beta-blockers, and the addition of other anti-anginal agents. A loop recorder was also implanted for ventricular tachycardia (VT) monitoring.

A few months after her consultation with the cardiothoracic surgeon, the patient was admitted to the hospital several times with a similar constellation of symptoms, including chest pain and left arm throbbing. Workup each time was unrevealing for an acute cardiac etiology. Her cardiac medications were optimized by up-titrating dosage of her beta blocker and adding isosorbide mononitrate as an additional antianginal agent, and her symptoms have since improved. Her implantable loop recorder showed one brief episode of atrial fibrillation with a rapid ventricular response, but no further episodes of VT.